BSE filing, NSE: ACUTAAS. Summary written from the filing by ALFA Finder's alert engine.
Acutaas Chemicals Ltd: key numbers
- Share price
- ₹3,690.00
- Market cap
- ₹30,210 Cr
- Revenue (annual)
- ₹1,339 Cr
- Net profit (annual)
- ₹356.3 Cr
- P/E (TTM)
- 68.8×Sector 46.5×
- Promoter holding
- 32.66%+0.00% QoQ
- FII holding
- 22.61%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Acutaas Chemicals Ltd
All →Acutaas Chemicals Earnings Call Transcript: Key Takeaways
Acutaas reports high-growth Q2 fueled by pharma intermediates and CDMO scaling, despite commodity chemical phase-outs.
- Call
- Guides 100% growth
Acutaas Chemicals Investor Presentation: Key Takeaways
Q2 FY27 revenue ₹4,369 Mn (+42.7% YoY), EBITDA ₹1,760 Mn (+84.6%, 40.3% margin), PAT ₹1,231 Mn (+71.4%). FY27 revenue guidance raised; South Korea semiconductor-chemicals facility inaugurated.
- Call
- Guides 30% growth
Acutaas Chemicals Results Update
Q2 FY27 revenue rose 42.7% YoY to ₹4,369 mn; PAT up 71.4% to ₹1,231 mn. Guidance raised to 30% revenue growth and 38-40% EBITDA margin.
Acutaas Chemicals Q2 FY27 Results: Net Profit ₹123.1 Cr, Up 71.2% YoY
Acutaas Chemicals Ltd reported revenue from operations of ₹436.9 Cr (+42.7% YoY) and net profit of ₹123.1 Cr (+71.2% YoY) for Q2 FY27.
- Key figure
- Net profit ₹123.1 Cr · +71.2% YoY
Acutaas Chemicals Financial Results
Acutaas Chemicals' board approved Q2 and half-year FY2027 unaudited results. The board meeting closed with no other material transaction disclosed.
Acutaas Chemicals Board Meeting Date
Acutaas Chemicals scheduled its board meeting for October 27, 2026, to approve Q2 and H1 FY27 unaudited results. No financial figures or decisions are reported, only the meeting date and agenda.
Other patent announcements
All →Aeroflex Industries Patent
Aeroflex Industries secured an Indian patent for automated 3D CAD modeling of braided hose assemblies. The grant underscores its R&D and engineering innovation focus.
Godavari Biorefineries Patent
Godavari Biorefineries Ltd has been granted a US patent for a compound targeting cancer treatment. This patent covers a novel class of cancer-inhibiting compounds.
Godavari Biorefineries Patent
Godavari Biorefineries Limited has been granted a patent by the Mexican Patent Office for its invention concerning compounds for treating viral infections.
Arrow Greentech Patent
Arrow Greentech Ltd has been granted a patent by the Singapore intellectual property office for its invention related to secure document laminates.
Uflex Patent
UFlex Limited received a patent from the Government of India for its 'High-Speed Twin Aseptic Pack Packaging Machine for Liquid Products'.
Godavari Biorefineries Patent
China's patent office granted Godavari Biorefineries a patent for compounds treating viral infections. The invention covers V-ATPase inhibition for medicament use.